William Blair & Company’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $31.3K | Sell |
|
|||||
|
2023
Q2 | $39.1K | Sell |
|
|||||
|
2023
Q1 | $35K | Sell |
|
|||||
|
2022
Q4 | $50.3K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $103K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $258K | Sell |
|
|||||
|
2021
Q3 | $2.9M | Buy |
|
|||||
|
2021
Q2 | $546K | Buy |
|
|||||
|
2021
Q1 | $555K | Buy |
|
|||||
|
2020
Q4 | $223K | Buy |
|